Lange BJ, Smith FO, Feusner J, Barnard DR, Dinndorf P, Feiget S, et al. Outcomes in CCG-2961, a children’s oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children’s oncology group. Blood. 2008;111:1044–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lange BJ, Gerbing RB, Feusner J, Skolnik J, Sacks N, Smith FO, et al. Mortality in overweight and underweight children with acute myeloid leukemia. JAMA. 2005;293:203–11.

Article  CAS  PubMed  Google Scholar 

Orgel E, Genkinger JM, Aggarwal D, Sung L, Nieder M, Ladas EJ. Association of body mass index and survival in pediatric leukemia: a meta-analysis. Am J Clin Nutr. 2016;103:808–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amankwah EK, Saenz AM, Hale GA, Brown PA. Association between body mass index at diagnosis and pediatric leukemia mortality and relapse: a systematic review and meta-analysis. Leuk Lymphoma. 2016;57:1140–8.

Article  PubMed  Google Scholar 

Hunter RJ, Navo MA, Thaker PH, Bodurka DC, Wolf JK, Smith JA. Dosing chemotherapy in obese patients: actual versus assigned body surface area (BSA). Cancer Treat Rev. 2009;35:69–78.

Article  CAS  PubMed  Google Scholar 

Sparreboom A, Wolff AC, Mathijssen RHJ, Chatelut E, Rowinsky EK, Verweij J, et al. Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese. J Clin Oncol. 2007;25:4707–13.

Article  CAS  PubMed  Google Scholar 

Colleoni M, Li S, Gelber RD, Price KN, Coates AS, Castiglione-Gertsch M, et al. Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index. Lancet. 2005;366:1108–10.

Article  CAS  PubMed  Google Scholar 

Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, et al. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2012;30:1553–61.

Article  PubMed  Google Scholar 

Mapp S, Sandhu G, Carrington C, Hennig S. A systematic review of treatment outcomes with weight-based dosing of chemotherapy in obese adult patients with acute leukemia or lymphoma. Leuk Lymphoma. 2016;57:981–4.

Article  PubMed  Google Scholar 

Inaba H, Surprise HC, Pounds S, Cao X, Howard SC, Ringwald-Smith K, et al. Effect of body mass index on the outcome of children with acute myeloid leukemia. Cancer. 2012;118:5989–96.

Article  PubMed  Google Scholar 

Tomizawa D, Tawa A, Watanabe T, Saito AM, Kudo K, Taga T, et al. Excess treatment reduction including anthracyclines results in higher incidence of relapse in core binding factor acute myeloid leukemia in children. Leukemia. 2013;27:2413–6.

Article  CAS  PubMed  Google Scholar 

Kinoshita A, Miyachi H, Matsushita H, Yabe M, Taki T, Watanabe T, et al. Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study Group. Br J Haematol. 2014;167:80–6.

Article  CAS  PubMed  Google Scholar 

Shiba N, Ohki K, Kobayashi T, Hara Y, Yamato G, Tanoshima R, et al. High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial. Br J Haematol. 2016;172:581–91.

Article  CAS  PubMed  Google Scholar 

Inokuchi M, Matsuo N, Anzo M, Hasegawa T. Body mass index reference values (mean and SD) for Japanese children. Acta Paediatr. 2007;96:1674–6.

Article  PubMed  Google Scholar 

Isojima T, Kato N, Ito Y, Kanzaki S, Murata M. Growth standard charts for Japanese children with mean and standard deviation (SD) values based on the year 2000 national survey. Clin Pediatr Endocrinol. 2016;25:71–6.

Article  PubMed  PubMed Central  Google Scholar 

de Onis M, Lobstein T. Defining obesity risk status in the general childhood population: which cut-offs should we use? Int J Pediatr Obes. 2010;5:458–60.

Article  PubMed  Google Scholar 

De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer / Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813–21.

Article  PubMed  Google Scholar 

Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.

Article  CAS  PubMed  Google Scholar 

Kristensen DT, Nielsen LB, Jakobsen LHK, Kristensen TCC, Jepsen LØ, Schöllkopf C, et al. Effects of chemotherapy dose reductions in overweight patients with acute myeloid leukaemia: A Danish nationwide cohort study. Br J Haematol. 2022;199:539–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huttunen R, Syrjänen J. Obesity and the outcome of infection. Lancet Infect Dis. 2010;10:442–3.

Article  PubMed  Google Scholar 

Dossett LA, Dageforde LA, Swenson BR, Metzger R, Bonatti H, Sawyer RG, et al. Obesity and site-specific nosocomial infection risk in the intensive care unit. Surg Infect (Larchmt). 2009;10:137–42.

Article  PubMed  Google Scholar 

Tsolakoglou I, Intas G, Stergiannis P, Sakkou A, Chalari E, Tsoumakas K, et al. Central-line-associated bloodstream infections (CLABSIs) incidence and the role of obesity: a prospective, observational Study in Greece. Adv Exp Med Biol. 2020;1196:11–8.

Article  PubMed  Google Scholar 

Falagas ME, Athanasoulia AP, Peppas G, Karageorgopoulos DE. Effect of body mass index on the outcome of infections: a systematic review. Obes Rev. 2009;10:280–9.

Article  CAS  PubMed  Google Scholar 

Tomizawa D, Tawa A, Watanabe T, Saito AM, Kudo K, Taga T, et al. Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group. Int J Hematol. 2013;98:578–88.

Article  CAS  PubMed  PubMed Central  Google Scholar